Complete Filing Data
Ardent Health, Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $1.69 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Ardent Health, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income * | $135.8M | $210.3M | $53.9M | $188.9M |
| Other Comprehensive Income Loss Net Of Tax | -$13.3M | -$8.8M | -$8.0M | $36.5M |
| Net Income Loss Attributable To Nonredeemable Noncontrolling Interest | -$96.7M | -$95.5M | -$78.6M | -$71.8M |
| Revenues | $6.32B | $5.97B | $5.41B | $5.13B |
| Other Comprehensive Income Loss Tax | -$4.7M | -$3.1M | -$2.8M | $12.9M |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax | -$18.1M | -$11.9M | -$10.8M | $49.4M |
| Other Comprehensive Income Loss Before Tax | -$18.1M | -$11.9M | -$10.8M | $49.4M |
| Nonoperating Gains Losses | $23.3M | $26.3M | $1.6M | $18.7M |
| Net Income Loss Attributable To Noncontrolling Interest | $94.3M | $89.4M | $75.1M | $76.5M |
| Income Tax Expense Benefit | $56.2M | $63.4M | $22.6M | $46.1M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $286.4M | $363.1M | $151.6M | $311.5M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $216.8M | $290.9M | $121.0M | $301.9M |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $94.3M | $89.4M | $75.1M | $76.5M |
| Comprehensive Income Net Of Tax | $122.5M | $201.5M | $45.9M | $225.4M |
| Interest Expense Operating | $55.2M | $65.6M | $74.3M | |
| Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income | $1.0M | -$5.8M | $1.7M | $7.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$23.5M | $73.0M | $41.4M | $26.3M | $42.8M | $27.0M | $20.8M | $33.1M | $4.1M |
| Other Comprehensive Income Loss Net Of Tax | -$2.2M | -$4.3M | -$5.8M | -$7.5M | -$2.3M | $703.0K | $31.0K | $4.6M | -$4.6M |
| Net Income Loss Attributable To Nonredeemable Noncontrolling Interest | -$24.4M | -$24.3M | -$18.9M | -$21.0M | -$25.5M | -$21.1M | -$17.8M | -$23.6M | -$20.4M |
| Revenues | $1.58B | $1.65B | $1.50B | $1.45B | $1.47B | $1.44B | $1.38B | $1.37B | |
| Other Comprehensive Income Loss Tax | -$791.0K | -$1.5M | -$2.1M | -$2.7M | -$796.0K | $248.0K | $12.0K | $1.6M | |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax | -$3.0M | -$5.9M | -$7.9M | -$10.2M | -$3.1M | $951.0K | $43.0K | $6.2M | |
| Other Comprehensive Income Loss Before Tax | -$3.0M | -$5.9M | -$7.9M | -$10.2M | -$3.1M | $951.0K | $43.0K | $6.2M | |
| Nonoperating Gains Losses | $2.6M | -$560.0K | $21.3M | $2.8M | $255.0K | $0.00 | $0.00 | $520.0K | |
| Net Income Loss Attributable To Noncontrolling Interest | $24.7M | $22.8M | $17.6M | $19.7M | $24.2M | $18.8M | $17.9M | $22.6M | |
| Income Tax Expense Benefit | -$3.4M | $26.3M | $15.2M | $11.1M | $15.2M | $10.7M | $7.3M | $12.1M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$2.2M | $122.0M | $74.2M | $57.1M | $82.2M | $56.6M | $46.0M | $67.8M | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$1.0M | $91.4M | $53.2M | $38.5M | $64.7M | $46.6M | $38.7M | $60.3M | |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $24.7M | $22.8M | $17.6M | $19.7M | $24.2M | $18.8M | $17.9M | $22.6M | |
| Comprehensive Income Net Of Tax | -$25.7M | $68.6M | $35.6M | $18.8M | $40.5M | $27.8M | $20.9M | $37.7M | |
| Interest Expense Operating | $13.9M | $14.7M | $14.2M | $14.6M | $18.2M | $19.3M | $19.0M | $18.7M | |
| Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income | $1.2M | -$1.3M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity * | $1.29B | $1.13B | $670.9M | $1.04B | $978.3M |
| Temporary Equity Net Income | $2.4M | $6.1M | $3.5M | -$4.7M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $709.6M | $556.8M | $437.6M | $456.1M | $718.2M |
| Minority Interest Decrease From Distributions To Noncontrolling Interest Holders | $88.2M | $72.9M | $63.9M | $61.8M | |
| Temporary Equity Carrying Amount Including Portion Attributable To Redeemable Noncontrolling Interests | |||||
| Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | $1.2M | $7.3M | $10.8M | $13.7M | |
| Gain Loss On Extinguishment And Modification Of Debt | -$7.3M | -$3.4M | $0.00 | $0.00 | |
| Repayments Of Long Term Debt | $8.0M | $108.4M | $13.6M | $17.3M | |
| Redeemable Noncontrolling Interest Equity Carrying Amount | -$1.3M | $1.2M | $7.3M | $10.8M | |
| Goodwill | $879.5M | $852.1M | $844.7M | $844.7M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $152.8M | $119.2M | -$18.5M | -$262.1M | |
| Self Insurance Liability Noncurrent | $241.1M | $227.0M | $243.6M | ||
| Retained Earnings Accumulated Deficit | $501.6M | $365.8M | $155.5M | ||
| Other Liabilities Noncurrent | $76.6M | $34.7M | $76.0M | ||
| Other Intangible Assets Net | $89.3M | $76.9M | $76.9M | ||
| Other Assets Noncurrent | $111.7M | $143.0M | $147.1M | ||
| Other Assets Current | $431.9M | $304.1M | $222.3M | ||
| Other Accrued Liabilities Current | $268.9M | $239.8M | $233.3M | ||
| Minority Interest | $398.3M | $389.8M | $404.1M | ||
| Long Term Debt Noncurrent | $1.08B | $1.09B | $1.17B | ||
| Long Term Debt Current | $23.4M | $9.2M | $18.6M | ||
| Liabilities Current | $1.05B | $945.4M | $994.1M | ||
| Liabilities And Stockholders Equity | $5.29B | $4.96B | $4.73B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $1.24B | $1.25B | $1.18B | $1.01B | $739.9M | $1.11B | $1.08B | $1.06B | $1.05B | ||
| Temporary Equity Net Income | -$262.0K | $1.6M | $1.4M | $1.3M | $1.3M | $2.3M | -$33.0K | $970.0K | $788.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $609.4M | $540.6M | $495.0M | $563.1M | $334.5M | $372.8M | $444.7M | $404.7M | |||
| Minority Interest Decrease From Distributions To Noncontrolling Interest Holders | $20.3M | $19.2M | $21.5M | $17.4M | $14.3M | $18.9M | $19.3M | $12.6M | |||
| Temporary Equity Carrying Amount Including Portion Attributable To Redeemable Noncontrolling Interests | -$1.5M | -$1.8M | -$192.0K | $1.2M | $2.4M | $3.7M | $5.0M | $7.3M | |||
| Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | $2.4M | $3.7M | $5.0M | $9.1M | $9.0M | $10.0M | |||||
| Gain Loss On Extinguishment And Modification Of Debt | -$7.3M | $0.00 | -$1.5M | -$1.9M | $0.00 | ||||||
| Repayments Of Long Term Debt | $1.4M | $3.5M | |||||||||
| Redeemable Noncontrolling Interest Equity Carrying Amount | -$1.5M | -$1.8M | -$192.0K | $2.4M | $3.7M | ||||||
| Goodwill | $877.5M | $877.7M | $876.6M | $852.0M | $852.0M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$61.7M | -$64.8M | |||||||||
| Self Insurance Liability Noncurrent | $260.6M | $220.8M | $226.5M | $232.0M | $240.6M | ||||||
| Retained Earnings Accumulated Deficit | $456.7M | $480.1M | $407.2M | $251.6M | $225.3M | ||||||
| Other Liabilities Noncurrent | $62.5M | $31.8M | $31.6M | $53.7M | $58.9M | ||||||
| Other Intangible Assets Net | $90.1M | $76.9M | $76.9M | $76.9M | $76.9M | ||||||
| Other Assets Noncurrent | $111.6M | $111.2M | $116.9M | $137.3M | $144.5M | ||||||
| Other Assets Current | $366.1M | $331.6M | $239.0M | $193.6M | $205.2M | ||||||
| Other Accrued Liabilities Current | $266.4M | $237.9M | $226.3M | $250.9M | $278.4M | ||||||
| Minority Interest | $395.1M | $393.5M | $389.5M | $378.6M | $419.1M | ||||||
| Long Term Debt Noncurrent | $1.09B | $1.09B | $1.09B | $1.08B | $1.08B | ||||||
| Long Term Debt Current | $19.3M | $19.3M | $17.8M | $12.2M | $10.7M | ||||||
| Liabilities Current | $943.2M | $880.9M | $830.1M | $887.3M | $908.6M | ||||||
| Liabilities And Stockholders Equity | $5.15B | $5.03B | $4.91B | $4.80B | $4.61B |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Proceeds From Payments For Other Financing Activities | -$5.2M | $5.2M | -$7.2M | -$10.3M |
| Proceeds From Issuance Of Long Term Debt | $0.00 | $3.6M | $6.6M | $878.0K |
| Proceeds From Insurance Financing Arrangements | $15.6M | $10.8M | $24.7M | $4.3M |
| Payments To Minority Shareholders | $88.2M | $72.9M | $63.9M | $69.4M |
| Payments To Acquire Businesses Net Of Cash Acquired | $2.5M | $35.5M | $0.00 | $0.00 |
| Payments For Proceeds From Productive Assets | $211.9M | $187.5M | $137.4M | $151.1M |
| Payments For Proceeds From Other Investing Activities | -$179.0K | $1.7M | $575.0K | $8.7M |
| Net Cash Provided By Used In Operating Activities | $470.5M | $315.0M | $221.7M | -$38.4M |
| Net Cash Provided By Used In Investing Activities | -$214.2M | -$220.5M | -$138.0M | $46.6M |
| Net Cash Provided By Used In Financing Activities | -$103.5M | $24.6M | -$102.3M | -$270.3M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $122.1M | $136.0M | $36.6M | -$8.3M |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $62.1M | -$103.9M | $136.8M | $14.4M |
| Increase Decrease In Inventories | $3.1M | $9.4M | -$1.7M | -$4.7M |
| Increase Decrease In Accrued Salaries | $686.0K | $27.5M | $22.9M | -$18.9M |
| Increase Decrease In Accounts Receivable | -$59.2M | -$40.0M | $181.1M | $17.2M |
| Depreciation Depletion And Amortization | $155.7M | $146.3M | $140.8M | $138.2M |
| Payments Of Stock Issuance Costs | $0.00 | $9.5M | $0.00 | $2.0M |
| Payments Of Debt Issuance Costs | $2.6M | $2.5M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 |
|---|---|---|
| Proceeds From Payments For Other Financing Activities | -$1.1M | $0.00 |
| Proceeds From Issuance Of Long Term Debt | $0.00 | $951.0K |
| Proceeds From Insurance Financing Arrangements | $11.0M | $0.00 |
| Payments To Minority Shareholders | $19.2M | $14.3M |
| Payments To Acquire Businesses Net Of Cash Acquired | $0.00 | $7.8M |
| Payments For Proceeds From Productive Assets | $22.9M | $23.8M |
| Payments For Proceeds From Other Investing Activities | $214.0K | $0.00 |
| Net Cash Provided By Used In Operating Activities | -$24.8M | -$14.7M |
| Net Cash Provided By Used In Investing Activities | -$23.1M | -$31.6M |
| Net Cash Provided By Used In Financing Activities | -$13.8M | -$18.5M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$36.0M | -$5.6M |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | -$46.7M | -$115.8M |
| Increase Decrease In Inventories | $5.2M | $453.0K |
| Increase Decrease In Accrued Salaries | -$80.9M | -$49.1M |
| Increase Decrease In Accounts Receivable | $30.7M | -$60.3M |
| Depreciation Depletion And Amortization | $36.2M | $35.4M |
| Payments Of Stock Issuance Costs | ||
| Payments Of Debt Issuance Costs |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 140.8M | 132.4M | 126.1M | 126.1M |
| Weighted Average Number Of Diluted Shares Outstanding | 141.5M | 132.7M | 126.1M | 126.1M |
| Earnings Per Share Diluted | $0.96 | $1.58 | $0.43 | $1.50 |
| Earnings Per Share Basic | $0.96 | $1.59 | $0.43 | $1.50 |
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | |
| Common Stock Shares Authorized | 750.0M | 750.0M | 0.00 | |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | |
| Preferred Stock Shares Authorized | 50.0M | 50.0M | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 141.2M | 140.4M | 140.1M | 137.1M | 126.1M | 126.1M | 126.1M | 126.1M |
| Weighted Average Number Of Diluted Shares Outstanding | 141.2M | 141.5M | 140.7M | 137.5M | 126.1M | 126.1M | 126.1M | 126.1M |
| Earnings Per Share Diluted | $-0.17 | $0.52 | $0.29 | $0.19 | $0.34 | $0.21 | $0.17 | $0.26 |
| Earnings Per Share Basic | $-0.17 | $0.52 | $0.30 | $0.19 | $0.34 | $0.21 | $0.17 | $0.26 |
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | ||||
| Common Stock Shares Authorized | 750.0M | 750.0M | 750.0M | 750.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | ||||
| Preferred Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Supplies Expense | $1.08B | $1.03B | $993.4M | $955.2M |
| Professional Fees | $1.19B | $1.10B | $980.3M | $736.3M |
| Other Cost And Expense Operating | $647.3M | $496.2M | $451.7M | $464.4M |
| Labor And Related Expense | $2.66B | $2.53B | $2.38B | $2.41B |
| Costs And Expenses | $6.04B | $5.60B | $5.26B | $4.82B |
| Cost Depreciation Amortization And Depletion | $155.7M | $146.3M | $140.8M | $138.2M |
| Stock Issued During Period Value New Issues | $738.0K | $904.0K | $611.0K | |
| Stock Option Plan Expense | $39.3M | $18.0M | $904.0K | $611.0K |
| Insurance Financing Arrangements Principal Payments | $15.0M | $10.4M | $22.9M | $3.8M |
| Government Assistance Income Expense | $0.00 | $0.00 | $8.5M | $16.8M |
| Capital Expenditures Incurred But Not Yet Paid | $16.4M | $9.3M | $16.4M | $9.7M |
| Amortization Of Financing Costs And Discounts | $4.4M | $5.5M | $5.0M | $5.7M |
| Prepaid Expense Current | $112.6M | $113.7M | $77.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Supplies Expense | $275.9M | $270.6M | $258.9M | $251.9M | $259.4M | $257.8M | $249.5M | $252.8M | |
| Professional Fees | $305.1M | $297.0M | $280.9M | $274.2M | $271.9M | $264.7M | $246.5M | $234.7M | |
| Other Cost And Expense Operating | $198.7M | $163.7M | $130.8M | $117.7M | $115.3M | $121.8M | $124.6M | $108.8M | |
| Labor And Related Expense | $677.0M | $671.7M | $657.7M | $635.2M | $624.1M | $621.5M | $595.6M | $598.3M | |
| Costs And Expenses | $1.58B | $1.52B | $1.42B | $1.39B | $1.39B | $1.38B | $1.33B | $1.30B | |
| Cost Depreciation Amortization And Depletion | $39.2M | $39.3M | $36.2M | $36.8M | $36.3M | $35.4M | $35.5M | $34.7M | |
| Stock Issued During Period Value New Issues | $199.1M | $226.0K | $512.0K | $181.0K | $182.0K | $360.0K | |||
| Stock Option Plan Expense | $9.3M | $512.0K | |||||||
| Insurance Financing Arrangements Principal Payments | $3.1M | $1.6M | |||||||
| Government Assistance Income Expense | $0.00 | $0.00 | $0.00 | $8.3M | |||||
| Capital Expenditures Incurred But Not Yet Paid | $6.7M | $1.2M | |||||||
| Amortization Of Financing Costs And Discounts | $1.2M | $1.4M | |||||||
| Prepaid Expense Current | $130.9M | $127.9M | $130.4M | $120.0M | $135.5M |
Most recent annual filing with the SEC: March 16, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.